Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

One Biotech Company Conducting the First Zika Vaccine Human Trial and Two Micro-Cap Companies Register Noteworthy Insider Buying

Executive officers and other key executives at most publicly traded companies are required to own shares of their companies worth at least three times their base salary within a specified period of hire or promotion (usually five years). The so-called ownership guidelines are aimed at linking the interests of executives and shareholders. Hence, investors should keep in mind this aspect when stumbling upon insider buying conducted by freshly-appointed employees or Board members.

It is generally believed that insider trading in smaller companies is much more informative than in larger ones. The “correct” price of a security should reflect each piece of material and non-material information related to that security. However, as less analysts and research hubs analyze and discuss smaller companies, it is likely that these companies are priced somewhat less inaccurately than larger companies. Assuming corporate insiders have a good feel for what the “correct” share price of their company is, observing insider buying at small companies may result in strong returns for investors. With that in mind, this article will discuss some insider buying recently registered at several small and relatively unknown companies.

Through extensive research, we have determined that the due diligence that the investors in our database employ, as well as their long-term focus makes them perfect targets to emulate. However, the results of our analysis have also shown that the small-cap picks of these funds can generate much better returns, with the 15 most popular small-cap stocks beating the market by an average of 95 basis points per month (read more details here).


This Spirits Company’s CEO Continues Buying up Shares

Castle Brands Inc. (NYSEMKT:ROX) has observed its most informed and powerful executive buy shares constantly over the past several months. Richard J. Lampen, President and Chief Executive Officer since October 2008, snatched up 120,000 shares on Monday, 72,300 shares on Tuesday, and 50,000 shares on Wednesday at prices ranging from $0.71 to $0.76 per share. Mr. Lampen also purchased a block of 20,200 shares on Friday for $0.72 each. After the recent purchases, Mr. Lampen currently owns 1.54 million shares.

The developer and marketer of premium and super-premium branded spirits has lost 41% of its market value since the beginning of 2016. Castle Brands Inc. (NYSEMKT:ROX) reported net sales of $72.22 million for fiscal 2016 that ended March 31, up from $57.46 million in fiscal 2015 and $48.14 million in fiscal 2014. However, the spirits company appears to be on track to become profitable in the following one or two years, as the company’s net loss declined to $1.71 million in fiscal 2016 from $3.47 million in fiscal 2015 and $7.97 million in fiscal 2014.

The company’s top line increased in fiscal 2016 due to sales growth of its Jefferson’s portfolio and its Goslings rum and Goslings Stormy Ginger Beer, partially offset by lower sales of vodka. Castle Brands anticipates sustained growth of Goslings Stormy Ginger beer in the near future due to the popularity of cocktails containing ginger beer and Goslings brand awareness. There were a mere four hedge funds followed by Insider Monkey invested in the spirits company at the end of March. Murray Stahl’s Horizon Asset Management owned 106,000 shares of Castle Brands Inc. (NYSEMKT:ROX) at the end of March.

Follow Castle Brands Inc (NYSEMKT:ROX)
Trade (NYSEMKT:ROX) Now!

The second page of this article will discuss the insider buying registered at two other companies.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.